Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064165%3A_____%2F12%3A13465" target="_blank" >RIV/00064165:_____/12:13465 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/12:13465
Result on the web
<a href="http://www.hindawi.com/crim/immunology/2012/978479/" target="_blank" >http://www.hindawi.com/crim/immunology/2012/978479/</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Intrapleural Bortezomib for the Therapy of Myelomatous Pleural Effusion: A Case Report
Original language description
Myelomatous pleural effusion (MPE) is an extremely rare manifestation of multiple myeloma (MM). We present a case of MPE in a patient with IgG-kappa MM treated with intrapleural bortezomib with systemic bortezomib-based therapy. Although we observed goodlocal response, the patient succumbed due to systemic myeloma progression.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2012
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Case Reports in Immunology
ISSN
2090-6609
e-ISSN
—
Volume of the periodical
2012
Issue of the periodical within the volume
ID 978479
Country of publishing house
US - UNITED STATES
Number of pages
3
Pages from-to
1-3
UT code for WoS article
—
EID of the result in the Scopus database
—